Rare Thyroid Therapeutics Company Details: 207 Social Audience

Rare Thyroid Therapeutics Overview

Headquarters: Se
Website: rarethyroid.com
Industry: Pharmaceutical Manufacturing
Employees: 6
Founded: 2017
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

orphan drugs Clinical trials Endocrinology Neurology Pediatric Pharmaceutical development MCT8 deficiency Thyroid hormone signalling AHDS

About Rare Thyroid Therapeutics

Rare Thyroid Therapeutics is a privately held pharmaceutical company, developing therapies for rare and neglected thyroid hormone disorders. Our lead product candidate Emcitate® is under development for the treatment of MCT8 deficiency, also called Allan-Herndon-Dudley Syndrome, a rare inborn X-linked disorder caused by a dysfunctional thyroid hormone transporter.